Organic Letters
Letter
ORCID
impurity effect are underway.
Interestingly, we found that the multifunctionalized cyclo-
pentene 3 can be further easily transformed into a multi-
functionalized cyclopentadienone oxime 19 (Scheme 4), with
2
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We acknowledge the financial support from the Ministry of
Science and Technology, Republic of China.
■
Scheme 4. Formation of (Z)-5-(Hydroxyimino)-2,4-
a
diarylcyclopenta-1,3-diene-1-carbonitrile 19
REFERENCES
1) (a) Das, S.; Chandrasekhar, S.; Yadav, J. S.; Gree
007, 107, 3286−3337. (b) Seemann, M.; Scho
■
(
2
́
, N. Chem. Rev.
ller, M.; Kudis, S.;
̈
Helmchen, G. Eur. J. Org. Chem. 2003, 2003, 2122−2127. (c) Hong, A.
Y.; Krout, M. R.; Jensen, T.; Bennett, N. B.; Harned, A. M.; Stoltz, B. M.
Angew. Chem., Int. Ed. 2011, 50, 2756−2760.
(
4
2) (a) Kim, K. H.; Miller, M. J. Tetrahedron Lett. 2003, 44, 4571−
573. (b) Chebib, M.; Duke, R. K.; Allan, R. D.; Johnston, G. A. R. Eur. J.
Pharmacol. 2001, 430, 185−192. (c) Liu, G.; Shirley, M. E.; Van, K. N.;
McFarlin, R. L.; Romo, D. Nat. Chem. 2013, 5, 1049−57.
(3) (a) Parker, W. B.; Shaddix, S. C.; Bowdon, B. J.; Rose, L. M.; Vince,
R.; Shannon, W. M.; Bennett, L. L., Jr. Antimicrob. Agents Chemother.
993, 37, 1004−1009. (b) Figadere, B. A.; McElfresh, J. S.; Borchardt,
1
̀
D.; Daane, K. M.; Bentley, W.; Millar, J. G. Tetrahedron Lett. 2007, 48,
8434−8437. (c) Srikrishna, A.; Beeraiah, B.; Ramesh Babu, R.
Tetrahedron: Asymmetry 2008, 19, 624−627. (d) Ishida, H.; Kimura,
S.; Kogure, N.; Kitajima, M.; Takayama, H. Tetrahedron 2015, 71, 51−
a
Reactions were performed on a 0.27 mmol scale. All yields
correspond to isolated yields with Z/E isomer ratio as determined
by H NMR of the crude mixture.
1
5
6.
4) (a) Gabor, B.; Mills, S. G.; Pasternak, A.; Shankarnan, K.; Yang, L.;
Zhou, C.; Globe, S. D. WIPO Patent Appl. WO 2004/041161A2, 2004.
b) Nair, A. G.; Kozlowski, J. A. U.S. Patent Appl. US 2013/0345254 A1,
013.
5) (a) Hansen, T.; Ausbacher, D.; Zachariassen, Z. G.; Anderssen, T.;
Havelkova, M.; Strøm, M. B. Eur. J. Med. Chem. 2012, 58, 22.
b) Hansen, T.; Ausbacher, D.; Flaten, G. E.; Havelkova, M.; Strøm, M.
(
assistance of catalytic TBAF at increased temperatures under
appropriate reaction conditions (see X-ray crystallography data
for 19aa and 19ai in SI). It is worth noting that the core
cyclopentadienone−oxime structures of these compounds can
be often found in many bioactive molecules as the modulators for
(
2
(
(
9
peroxisome proliferated activated receptor. Further detailed
B. J. Med. Chem. 2011, 54, 858.
studies about these novel transformation reactions are underway.
In conclusion, we successfully developed a new and effective
method for the synthesis of a wide variety of multifunctionalized
cyclopentenes. The reaction proceeds well under mild conditions
to give highly diastereoslective compounds and can tolerate both
the electron-donating and electron-withdrawing substituents on
the substrates. Moreover, these highly functionalized cyclo-
pentenes can serve as the precursors for making highly
functionalized cyclopentadienone oximes.
(6) (a) Wei, Y.; Shi, M. Org. Chem. Front. 2017, 4, 1876−1890 and
references therein. (b) Nair, V.; Menon, R. S.; Biju, A. T.; Sinu, C. R.;
Paul, R. R.; Jose, A.; Sreekumar, V. Chem. Soc. Rev. 2011, 40, 5336−5346.
(c) Tian, J.; He, Z. Chem. Commun. 2013, 49, 2058−60. (d) Leemans,
E.; D'hooghe, M.; De Kimpe, N. Chem. Rev. 2011, 111, 3268−3333.
(e) Vink, M. K. S.; Wijtmans, R.; Reisinger, C.; van den Berg, R. J. F.;
Schortinghuis, C. A.; Schwab, H.; Schoemaker, H. E.; Rutjes, F. P. J. T.
Biotechnol. J. 2006, 1, 569 and references therein. (f) Xu, L. W.; Gao, P.
S.; Li, N.; Zhang, J. L.; Zhu, Z. L.; Gao, Z.-W.; Sun, H. M.; Zhang, W. Q.
ChemCatChem 2016, 8, 3466−3474. (g) Ziegler, D. T.; Riesgo, L.;
Ikeda, T.; Fujiwara, Y.; Fu, G. C. Angew. Chem., Int. Ed. 2014, 53, 13183−
13187. (h) Zhang, H. J.; Meng, T.; Demerseman, B.; Bruneau, C.; Xi, Z.
Org. Lett. 2009, 11, 4458−4461. (i) Blom, J.; Vidal-Albalat, A.;
Jørgensen, J.; Barløse, C. L.; Jessen, K. S.; Iversen, M. V.; Jørgensen,
K. A. Angew. Chem., Int. Ed. 2017, 56, 11831−11835 and references
therein.
ASSOCIATED CONTENT
Supporting Information
■
*
S
(7) Paike, V. V.; Balakumar, R.; Chen, H. Y.; Shih, H. P.; Han, C. C.
Org. Lett. 2009, 11, 5586−5589.
(
(8) Han, J.; Kaspersen, S. J.; Nervik, S.; Nørsett, K. G.; Sundby, E.;
Hoff, B. H. Eur. J. Med. Chem. 2016, 119, 278−299 and references
therein.
(9) (a) Tseng, C. H.; Tung, C. W.; Wu, C. H.; Tzeng, C. C.; Chen, Y.
H.; Hwang, T. S.; Chen, Y. L. Molecules 2017, 22, 1001. (b) Cheon, H.
G.; Yoo, S. E.; Kim, S. S.; Yang, S. D.; Kim, K. R.; Rhee, S. D.; Ahn, J. H.;
Kang, S. K.; Jung, W. H.; Park, S. D.; Kim, N. G.; Lee, J. H.; Huh, S. C.;
Lee, J. M.; Song, S. B.; Kwon, S. J.; Kim, J. H.; Lee, J. H.; Kim, S. J. PCT
Int. Appl. WO2005/100303 A1, 2005.
Crystallographic Data Centre, 12 Union Road, Cambridge CB2
1EZ, UK; fax: +44 1223 336033.
AUTHOR INFORMATION
■
D
Org. Lett. XXXX, XXX, XXX−XXX